Cited by 51Ovarian function and disordersSexual Differentiation and DisordersAdrenal Hormones and Disorders

Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome

Open access
Koskinen, Pertti, Penttilä, Tuula-Anneli, Anttila, Leena, Erkkola, Risto, Irjala, Kerttu·1996·Fertility and Sterility

Abstract

Objective To investigate, using logistic regression analysis and receiver operator characteristic analysis, the biochemical diagnosis of polycystic ovary syndrome (PCOS) and if it could be improved by using an array of hormone measurements chosen to yield optimal and cost-effective discrimination between women with PCOS and healthy women.Design Retrospective clinical study.Setting Outpatient clinic of reproductive endocrinology at Turku University Central Hospital, Turku, Finland.Patients Fifty-four oligomenorrheic women with PCOS diagnosed by ovarian ultrasonography, and 29 healthy regularly menstruating women with normal ovarian morphology.Main outcome measures Concentrations of LH, FSH, androstenedione (A), T, and sex hormone-binding globulin in serum.Results Luteinizing hormone, FSH and A, when used in combination, were the hormonal analytes of highest clinical utility. Diagnostic sensitivity, specificity, and overall concordance of 98%, 93%, and 96%, respectively, were attained. Each of the analytes used alone yielded lower degree of discrimination.Conclusions Simultaneous use of the levels of LH, FSH, and A in serum can be used effectively for classification between women with PCOS and healthy women.

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(16)58146-1

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The remaining two studies provided insufficient lower-quality evidence to support any differences between total testosterone, SHBG and androstenedione levels with respect to their value in PCOS diagnosis.

    “The remaining two studies provided insufficient lower-quality evidence to support any differences between total testosterone, SHBG and androstenedione levels with respect to their value in PCOS diagnosis. 60,62”
  • Three diagnostic studies (NHMRC level III-2) with low, moderate and high risk of bias compared the diagnostic accuracy of different reproductive hormone markers in serum to detect PCOS.

    “Three diagnostic studies (NHMRC level III-2) with low, moderate and high risk of bias compared the diagnostic accuracy of different reproductive hormone markers in serum to detect PCOS. 60-62”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Koskinen, P., Penttilä, T.-A., Anttila, L., Erkkola, R., & Irjala, K.
Affiliations
Turku University Hospital (FI)
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
1996-03
Volume
65
Issue
3
Pages
517-522
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2402774334
Cited by
51
References
26
Citations by year
2024: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 4
FWCI
3.90
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
polycystic ovary syndrome, biochemical diagnosis, luteinizing hormone, follicle-stimulating hormone, androstenedione, sex hormone-binding globulin, testosterone, oligomenorrhea, sensitivity and specificity
MeSH terms
Adolescent, Adult, Androgens, Androstenedione, Female, Follicle Stimulating Hormone, Gonadotropins, Pituitary, Humans, Luteinizing Hormone, Polycystic Ovary Syndrome, Reference Values, Retrospective Studies, Sensitivity and Specificity, Sex Hormone-Binding Globulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review